分类： 其他平台
2013-10-29 17:34:03
First quarter knee sales growth was driven by continued strong demand worldwide for the Vanguard Complete Knee System and the Oxford Unicompartmental Knee System. The Vanguard Complete Knee System, the most comprehensive total knee system on the market today, provides full interchangeability of the system's femoral and tibial components to address virtually any anatomical difference regardless of the patient's race, gender, stature or any other variables. The Vanguard is engineered to provide precise fit for all patients while providing greater bone preservation and competitive high flex systems. The Vanguard System can be implanted using Biomet's microplasty minimally invasive knee instruments or the Vanguard premier instrumentation.
Biomet continues to lead the market in minimally invasive total knee instrumentation as a result of its pioneering work and its technology. during the past three fiscal years.
The Vanguard premiere instrumentation rollout continued during the first quarter with approximately 270 sets now in the field. The premier instrumentation is designed for implantation of the Vanguard System utilizing a conventional open procedure. has experienced excellent longterm clinical success outside the United States. Results include a 98% success rate at ten years follow up, 95% success at 15 years, with 93% success reported at 20 years. During the first quarter of fiscal '07, 160 domestic surgeons completed Oxfordspecific training with approximately 1,500 surgeons trained during the past two years. During the second quarter, training for the Oxford system is planned for an addition 125 surgeons.
Biomet's new revision knee system, the Vanguard SSK Super Stabilized Knee, continued to receive excellent market acceptance during the first quarter, as well as the Vanguard PFR patellofemoral replacement, a conservative treatment option for patients with cartilage degeneration isolated in the front mid section of the knee.
On October 25th, the California hospital medical center in Los Angeles will broadcast the first live webcast of the implementation of the Vanguard SSK Revision System which will be performed by Dr. Edward McPherson of the Los Angeles Orthopedic Institute.
The Vanguard SSK features various modular options that provide surgeons with the ability to customize the implant to accommodate the specific needs of an individual patient. Additionally, the modularity of the Vanguard SSK gives surgeons the ability to address complex bone defects often present in revision cases.
During the first quarter, we also continued to roll out Vanguard anterior stabilized implants and instruments. Additionally, the enrollment with the IDE study relating to the rotating platform version of the Vanguard was initiated during the quarter.
Next we'll look at hip sales. During the first quarter, hip sales increased 8% worldwide and 3% in United States against last year's first quarter growth rate of 12% worldwide and 7% in the United States. Biomet's alternativebearing products continued to repeat strong worldwide market acceptance during the first quarter while the M2aMagnum continued to further penetrate the metalonmetal acetabular market.
